Navigation Links
BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
Date:4/29/2009

through economic uncertainty. Our balance sheet and liquidity positions remain very strong, thanks to our ongoing efforts to proactively manage our capital structure. The refinancing of our joint venture's secured acquisition and interim loan is especially noteworthy as it extended the maturity by two years, with an option for an additional year, and demonstrated the support and commitment of our lending partners in an otherwise highly restrictive credit market. And, we are making solid progress on refinancing our upcoming loan maturities, including securing permanent financing for our Center for Life Science | Boston asset."

Portfolio Update

During the quarter ended March 31, 2009, the company executed 13 leasing transactions representing approximately 420,000 square feet, including nine new leases totaling approximately 121,000 square feet and four leases amended to extend their terms totaling approximately 299,000 square feet.

As of March 31, 2009, BioMed owned or had interests in 69 properties with 112 buildings, located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. The company's portfolio included the following as of March 31, 2009:

                                                      Rentable
                                                     Square Feet
                                                     -----------
    Operating portfolio                               8,233,988
    Repositioning and redevelopment properties        1,543,858
    Construction in progress                            736,708
                                                     ----------
      Total portfolio                                10,514,554
                                                     ----------

    Land parcels                                      1,352,000
  
'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
2. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
3. Four legendary LA BioMed physician-researchers honored
4. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
5. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
6. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
7. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
8. Response Biomedical Corporation Reports 2008 Financial Results
9. Advance Internet Launches HireBioMedical.com
10. Hollow gold nanospheres show promise for biomedical and other applications
11. Foundation for Biomedical Research Releases Groundbreaking PSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Regents Health Resources, a consulting ... brought health care industry veteran Daryl Demonbreun and former ... lead the company’s ambitious plans to grow into a ... been moving along at a steady pace for nearly ... a notch,” says Bob Maier, founder and chief executive ...
(Date:7/29/2014)... iFitDress.com, a well-known wedding dress manufacturer and retailer, has unveiled ... from this, it has announced that all of them are ... of its old and new clients may now access the ... “We are pleased to release the new collection of satin ... of amazing items. It is true that our satin bridal ...
(Date:7/29/2014)... 2014 Dignity Sciences Limited, a privately ... a Phase I trial with DS107G, an oral formulation ... was a randomized, placebo-controlled, double-blind, single-ascending and multiple dose ... and effect of food on DS107G in healthy subjects. ... of DGLA following both single and multiple oral doses ...
(Date:7/29/2014)... discovered a chemical alteration in a single human gene ... studies, could give doctors a simple blood test to ... The discovery, described online in The American Journal ... involved in the function of the brain,s response to ... might otherwise be an unremarkable reaction to the strain ...
(Date:7/29/2014)... Daily Gossip reveals in its Nasal Polyps ... that he cured his condition with the use of this ... of his experience. , He claimed that he was ... just 4 days. Since his method turned out being so ... around the world. , The Nasal Polyps Treatment Miracle ...
Breaking Medicine News(10 mins):Health News:Sferrella and Demonbreun Join Regents Health Resources 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Nasal Polyps Treatment Miracle Review Reveals How to Cure Nasal Polyps Without Surgery 2
... the US Food and Drug Administration gave its approval ... in the treatment of chronic Hepatitis B// (HBV). Clinical studies ... effects and is usually well tolerated. ,Hepatitis B ... 70,000 Americans every year. It is a serious illness and ...
... workplace cafeterias and vending machines, to understand the nature of ... in the levels of obesity, this is certainly called for, ... diseases. ,The Ministry of Health will keep ... next two years to ascertain the types of food enabled ...
... vaccine are underway in Mozambique, certainly not a farfetched goal ... The production// of the vaccine is estimated at about $60-million. ... addressing a gathering of health officials said 'We think the ... tests in Manhica (north of the capital Maputo) are effective. ...
... boy died of dengue fever here Wednesday, taking the toll ... as officials maintained that the number of cases had dropped ... Pradesh, died at the All India Institute of Medical Sciences ... in a critical condition. , ,"His condition was deteriorating ...
... light on the alarming trend among teenage girls taking to smoking//, ... to dispel the myth that smoking helps in controlling weight. , ... much the same way as their peers who do not smoke. ... which deserves to be puffed out. , ,Dr. Louise Pilote, ...
... dose of folic acid every day could have better chance of ... a form of vitamin B is used in our bodies to ... her body before she is pregnant, it can help prevent major ... latest study involving more than 18,000 women for the first time ...
Cached Medicine News:Health News:13-Year-Old Boy Is Latest Dengue Victim; Delhi Toll 47 2Health News:Folic Acid Supplements Could Help Conception 2
(Date:7/29/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... specific pathogens that cause serious infections and diseases, announced ... in the Company,s stock, the NYSE MKT (the "Exchange") ... practice. The Company stated that its policy is not ... Synthetic Biologics, Inc. Synthetic Biologics, Inc. (NYSE ...
(Date:7/29/2014)... Numotion,s Board of Directors has announced that as ... the company,s new Chief Executive Officer. Swinford ... where he worked primarily for GE Healthcare Services, running businesses ... billion. His most recent position was as President and CEO ... thrilled to join Numotion," said Mike Swinford . "I ...
(Date:7/29/2014)... ALBANY, New York , July 29, 2014 /PRNewswire/ ... published by Transparency Market Research "Orthopedic Trauma Fixation Devices ... Industry Analysis 2014 - 2020", the global orthopedic trauma ... in 2014 and is expected to grow at a ... an estimated value of USD 9.3 billion in 2020. ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Numotion Names Mike Swinford CEO 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
0.12 1x2 tips on a 2.5mm platform; Stainless Steel Tip; 32mm shaft; Titanium Handle....
Straight shafts with fine Pierse type tips on a 5mm platform; In Titanium...
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Curved Shaft with 5mm Platform; 1x2, 0.12 mm teeth; In Titanium....
Medicine Products: